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Background: There is limited evidence regarding predictors associated with clinical
outcomes of patients with chronic total occlusion (CTO) successfully treated with
drug-eluting stents (DESs).
Methods: We investigated the 249 patients (pts) with de novo CTO lesions suc-
cessfully treated with DESs from 2004 to 2010. All major adverse cardiovascular
events (ALL-MACEs) were deﬁned as composite of total death, any myocardial
infarction (MI), target vessel revascularization (TVR) and non-target vessel revas-
cularization. The association of ALL-MACEs with clinical, biochemical and pro-
cedural variables including age, male gender, hypertension, diabetes mellitus,
smoking, hyperlipidemia, acute MI, multi-vessel disease, left main involvement,
prior PCI, cilostazol, left ventricular ejection fraction <30 %, Hemoglobin level,
Creatinine level, LDL-cholesterol<100 mg/dL, Glycated hemoglobin<7.0 %, High
sensivity-CRP, number of total stents, IVUS-guided PCI, adjuvant ballooning was
examined.
Results: The 12-month follow-up has been performed in the 242 of 249 pts (97.2%).
The incidence of ALL-MACEs was the 40 of 242 patients (16.5%). Multivariate
logistic regression was used to identify predictors affecting 1-year ALL-MACE. Left
main involvement was signiﬁcantly associated with 1-year ALL-MACEs and prior
PCI history had a trend to be associated with 1-year ALL-MACEs (Table).
Conclusion: In our study, left main involvement was an important independent
predictor associated with 1-year MACE following successful CTO intervention with
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Background: Myocardial infarction (MI) is known to be associated with increased
adverse clinical outcomes in coronary artery diseases. The impact of percutaneous
coronary intervention (PCI) for CTO in patients with myocardial infarction is not
clear. We evaluated the 12-month clinical outcomes between PCI and optimal medical
therapy (OMT) for CTO lesions in MI patients.
Methods: A total of 143 consecutive CTO patients who were admitted for MI were
divided into 2 groups according to treatment strategy; PCI group (n¼68) and OMT
group (n¼75). 12-month clinical outcomes were compared between the two groups.
Results: At baseline, patients in the OMT group showed a higher prevalence of
elderly, hyperlipidemia, peripheral vascular disease, de novo lesion, non-CTO pro-
cedure, multivessel disease, and LCX-CTO. Patients in the PCI group showed a
higher prevalence of prior MI, prior PTCA, and LAD-CTO lesion. Clinical out-
comes at 12 months showed lower mortality and lower rates of recurrent MI in the
PCI group. After baseline adjustment by multivariate analysis, however, there was no
difference.
Conclusion: In our study, intervention shows a possibility of being a favorable choice
of therapy for CTO lesions in MI patients in terms of 12-month mortality and MI-
related morbidity. Long-term follow up with a larger study population will be
necessary for further determination of the beneﬁt and risks of interventional therapy in
CTO patients.
